A cancer therapy that uses genetically engineered immune cells, called CAR T-cells, has kept a person free of a potentially fatal nerve tumour for a record-breaking 18 years. “This is ...
Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.
Feb. 19, 2025 — Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could ...
The stages indicate how far cancer has spread and the size of any tumors. Usually, cells follow an orderly process of growth, division, and death. Cancer can develop when cells grow and divide ...
Median survival is the amount of time at which 50% of people with a condition 50% are still alive and 50% have died. There are two basic types of lung cancer: small cell (SCLC), the most aggressive ...
A woman who received CAR-T-cell therapy has now been in cancer remission for 19 years. Plus, a genetic swap makes mice squeak differently.
Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune system fight tumors in ovarian cancer. The study, published in Science ...
Dr. Vinod Balachandran says mRNA vaccines could stimulate the immune system to recognize and attack pancreatic cancer cells. An experimental approach to treating pancreatic cancer with the messenger ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
They’re sharing the same stem cells. “We put family first,” said ... an aggressive form of blood cancer. “It’s been rough,” said Brewer. “It’s been heavy,” added Ruhmann.
1Division of Gynecologic Oncology, Department of OB/GYN, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York. Search for other works by this author on: 1Division of ...